T1	Caption 8424 8578	Figure 1 Individual maternal antibody (maAb) titre (n = 282) of the 64 fox cubs born to vaccinated vixens during the experimental study conducted in 2000.
A1	Type T1 Figure
A2	Num T1 1

T2	Reference 8297 8423	This diminishing variance was particularly obvious in those cubs having maAb-titres above the threshold of 0.5 IU/ml (Fig. 1).
A3	RefType T2 Direct
A4	Type T2 Figure
A5	Num T2 1

T3	Caption 9137 9362	Figure 2 Maternal antibody (maAb) titres (n= 499) of the combined data sets of the years 1998–2000 together with the linear regression line indicating the overall trend in the development of log(maAb) of cubs with age [days].
A7	Type T3 Figure
A8	Num T3 2

T4	Reference 9004 9136	A regression line was fitted to the data, with significant linear (p < 0.0001) decrease of log(maAb) with increasing age (Figure 2).
A9	RefType T4 Direct
A10	Type T4 Figure
A11	Num T4 2

T5	Caption 10166 10312	Figure 4 Relation between the neutralizing antibody titre (nAb) of the vixen and the time (age) when maAb of cubs disappear (<0.5 IU/ml) in RFFIT.
A13	Type T5 Figure
A14	Num T5 4

T6	Reference 9741 9920	Using equation (2) the critical mean age when cubs' titres equal 0.5 IU/ml in RFFIT was 23 days (range: 14 – 38 days) depending on the nAb-titre of the immunised vixen (Figure 4).
A15	RefType T6 Direct
A16	Type T6 Figure
A17	Num T6 4

